Proxalutamide Treatment for Hospitalized COVID-19 Patients

Clinical trial NCT04728802 · COMPLETED

Trial details

NCT number: NCT04728802
Sponsor: Applied Biology, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Covid19 SARS (Severe Acute Respiratory Syndrome)

Start date: 2021-02-01
Primary completion: 2021-04-15
Enrollment: 645

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.